← signals
2026-07-09·OPENAI·hyperscaler internal chip
lowup

Prediction markets show strong consensus that OpenAI will design and manufacture a custom AI chip by 2030, with...

Prediction markets show strong consensus that OpenAI will design and manufacture a custom AI chip by 2030, with probability at 93.15% (Source 2: Simultaneously, the market assigns only 24.71% probability to OpenAI publicly sharing software to run AI on chips from different providers by 2026 (Source 1: This divergence suggests a strategic pivot toward vertical integration and proprietary hardware, reducing reliance on external GPU suppliers.

window 30devidence 18confidence score 91

confidence score

Strong evidence: 1 independent source class support this read.

91
low confidence1 independent source classesmarketpasses publish gate

signal brief

Prediction markets show strong consensus that OpenAI will design and manufacture a custom AI chip by 2030, with probability at 93.15% (Source 2: https://manifold.markets/NicholasCharette73b6/will-openai-design-and-manufacture). Simultaneously, the market assigns only 24.71% probability to OpenAI publicly sharing software to run AI on chips from different providers by 2026 (Source 1: https://manifold.markets/Bayesian/will-openai-publicly-share-software). This divergence suggests a strategic pivot toward vertical integration and proprietary hardware, reducing reliance on external GPU suppliers. The high probability of custom chip development implies significant capex allocation to silicon design and potential partnerships with foundries like TSMC. If realized, this could reshape AI infrastructure competition and pressure incumbent GPU vendors.

What the sources said:

  • Source 2: 'Will OpenAI design and manufacture a custom AI chip by 2030? YES=93.15%' (high market belief in internal silicon).
  • Source 1: 'Will OpenAI publicly share software to make its AI run on chips from different providers, in 2026? YES=24.71%' (low expectation of multi-hardware software sharing).

source data used

Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.